Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderHDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammationA new avenue for lithium: intervention in traumatic brain injury.Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction.The incidence and relative risk of stroke among patients with bipolar disorder: a seven-year follow-up study.Protection of Neurovascular Unit Cells with Lithium Chloride and Sodium Valproate Prevents Brain Damage in Neonatal Ischemia/Hypoxia.Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia.Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic strokeTubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of α-tubulin acetylation and FGF-21 up-regulationValproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3Inhibiting endoplasmic reticulum stress by lithium chloride contributes to the integrity of blood-spinal cord barrier and functional recovery after spinal cord injury.Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration.Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathways.Lithium modulates cancer cell growth, apoptosis, gene expression and cytokine production in HL-60 promyelocytic leukaemia cells and their drug-resistant sub-clones.Delayed neuroprotection against cerebral ischemia reperfusion injury: putative role of BDNF and GSK-3β.
P2860
Q24626017-13207868-4944-4DA5-8C42-3FD0C8DD40F1Q33757971-2B742F47-9DD7-4486-8F3B-CD2816B4A6DAQ33777980-BAFC9D52-7ECD-4A17-92B7-FB675432887EQ34978817-07E702DD-B12C-47E5-92D8-2AD417ADAC88Q34983689-B75A0387-1C13-4F94-977B-2A0E5415BD29Q35888309-DAF68355-CFCE-4AED-8236-7E00E9F95F05Q36185344-AC9A22E1-8005-4300-A975-43C4E3396980Q36195297-E44CC1F7-4E36-4CB3-9EC7-3DE2BBBE9C8BQ36500444-35B6B1EC-81C2-4617-AD25-22BD874A33AAQ37220495-E45B4675-B189-470F-9D43-DBBCA0ABF256Q37732967-B84C90A8-3751-4864-BD36-B577180478D1Q39008341-5DA4F2F0-4023-4391-ABE2-CC77E5409CC5Q39812275-801B55BB-D0E0-4787-AF86-62A189588B33Q46341360-23B991E7-D319-4DB7-B2FD-7913859DC58DQ52146972-85C24105-10DC-412A-999D-B22ED20AD52F
P2860
Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Beneficial effects of mood sta ...... in experimental stroke models.
@ast
Beneficial effects of mood sta ...... in experimental stroke models.
@en
Beneficial effects of mood sta ...... in experimental stroke models.
@nl
type
label
Beneficial effects of mood sta ...... in experimental stroke models.
@ast
Beneficial effects of mood sta ...... in experimental stroke models.
@en
Beneficial effects of mood sta ...... in experimental stroke models.
@nl
prefLabel
Beneficial effects of mood sta ...... in experimental stroke models.
@ast
Beneficial effects of mood sta ...... in experimental stroke models.
@en
Beneficial effects of mood sta ...... in experimental stroke models.
@nl
P2093
P2860
P356
P1476
Beneficial effects of mood sta ...... in experimental stroke models.
@en
P2093
De-Maw Chuang
Emily Bame Fessler
Zhi-fei Wang
P2860
P2888
P304
P356
10.1038/APS.2011.140
P577
2011-11-07T00:00:00Z
P5875
P6179
1020383790